Chiasma (CHMA) OPTIMAL Trial Data Sets Stage For Positive NDR - Cantor
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes reiterated an Overweight rating and $18.00 price target on Chiasma (NASDAQ: CHMA) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
